Results 101 to 110 of about 18,081 (213)

Targeting proprotein convertase subtilisin/kexin type 9 in mice and monkeys

open access: green, 2019
Wang Ya   +4 more
openalex   +2 more sources

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus [PDF]

open access: gold, 2020
Hiurma Sánchez‐Pérez   +6 more
openalex   +1 more source

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients

open access: yesTherapeutics and Clinical Risk Management, 2019
Chin-Chou Huang,1–5 Min-Ji Charng2,3 1Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; 2Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 3Faculty of Medicine, School
Huang CC, Charng MJ
doaj  

The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer

open access: green, 2020
Zongsheng He   +7 more
openalex   +2 more sources

PACE4 (PCSK6): another proprotein convertase link to iron homeostasis?

open access: yesHaematologica, 2015
Johann Guillemot, Nabil G. Seidah
doaj   +1 more source

Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver

open access: diamond, 2020
Muhammad Shafiq   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy